MTND6P12

Across TCGA pan-cancer cohorts, MTND6P12 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MTND6P12’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where MTND6P12 RNA is repressed in tumor relative to normal tissue. In most cancer types MTND6P12 is over-expressed in tumor, although a few such as COAD and STAD show the opposite, repressed pattern.

COAD and STAD are the cancer types where MTND6P12 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND6P12 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	−0.025	.010	4	view →
STAD	Male	II,III,IV	−0.066	.031	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MTND6P12–COAD

Open the COAD breakdown →